🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It's #BreastCancerAwarenessMonth, our team wants to remind everyone that early detection saves lives, as does #Research and #PrecisionMedicine! Weill Cornell Breast Center Weill Cornell Medicine

Today is National #MetastaticBreastCancer Awareness day, and we are participating in the #4ForStageIV campaign by Living Beyond Breast Cancer - Early Detection - Research - Access to Care - Clinical Trials Weill Cornell Breast Center Weill Cornell Medicine NewYork-Presbyterian #StageIVneedsMore

Time to integrate liquid biopsy for a real-time assessment of HER2 status in patients with BC? Our review in the International Society of Liquid Biopsy journal outlines opportunities and challenges of HER2 evaluation on CTCs doi.org/10.1016/j.jlb.… Cristofanilli CTC Laboratory @MCristofanill Carolina Reduzzi G Curigliano MD PhD

Over 300,000 people will be diagnosed with #BreastCancer in the U.S. this year, according to American Cancer Society. This #BCAM, our teams #WearPink to support those impacted by this disease. Learn about our compassionate #cancer care: nyphosp.co/3PTysvm Columbia Medicine, Weill Cornell Medicine

ESMO23 will have a relevant impact on the way we treat breast cancer. Practice will be changed, shaped and/or challenged by several of the studies presented this week in Madrid. Here’s a personal selection of 10 #ESMO23 breast cancer abstracts not to miss. #bcsm

The WCM Englander Institute for Precision Medicine's Scientific Director Dr. Massimo Cristofanilli (@MCristofanill) talked with Spectrum News NY1 News about the use of #liquidbiopsy in detecting and treating #BreastCancer as early as possible. #BreastCancerAwarenessMonth muckrack.com/broadcast/save…

#HappyHalloween from The Cristofanilli’s CTC Laboratory #LiquidBiopsy #CTCs #ctDNA #PrecisionMedicine #TranslationalResearch #BenchToBesideCare Weill Cornell Breast Center

It was a great honor to have been introduced by Professor @MCristofanill in this important milestone of my life. Thanks to him and Professor Bria for the mentoring. Cristofanilli CTC Laboratory Università Cattolica Weill Cornell Breast Center

"Growing is never-ending. As long as you keep learning & evolving you will never stop growing!" #ctDNA #CTCs #LiquidBiopsy Carolina Reduzzi Jeannine Licolli Donahue (Alvim) Eleonora Nicolò Letizia Pontolillo Nadia Bayou Laura Sofia Munoz Arcos @MCristofanill Weill Cornell Breast Center WCM Englander Institute for Precision Medicine

#ISLB23 Annual Congress: Sneak Preview! Panel Discussion #2 of multidisciplinary stakeholder workshop on drug & biomarker development, consisting of reps from academics, regulatory bodies, patient advocates, Pharma and Biomarker. Goal: to reach consensus

#ISLB23 It was an amazing Meeting for several reasons: the 400 worldwide participants 34 countries 🌍the 55 international speakers, 115 abstracts of high quality, the discussions but the best the engagement & great atmosphere. We are a big family! Looking forward to #ISLB24 !

The WCM Englander Institute for Precision Medicine Scientific Director Dr. Massimo Cristofanilli (@MCristofanill) will present a Weill Cornell Medicine Physician Scientist Seminar Series lecture, "Liquid biopsy in #breastcancer: Can we use the patient as a new translational model?" Wednesday at noon via Zoom.

Dr. Eleni Andreopoulou (Eleni Andreopoulou, MD) spoke with Greek news outlet mononewsgr about #BreastCancer #research, treatment, screening, the aims of #PrecisionMedicine, and her personal perspective as a female physician: bit.ly/4bAZOAg (cc: WCM Englander Institute for Precision Medicine)

🚨🔔ISLB 2024 - Save The Date! 23-25 November 2024 in Denver Colorado!. 🏔️🌆Subscribe for the newsletter and prepare your abstracts!! ⁦M JOSE SERRANO Lab (LB&Cancer Interception group)⁩ ⁦Umberto Malapelle⁩ ⁦David Gandara⁩ ⁦@MCristofanill⁩ ⁦ELO⁩ ⁦ 2024.islb.info

Our next #PrecisionMedicine Research Conference, "Discussion of Clinical #WGS and Research Whole Exome and #RNASeq," will be presented by Dr. Daniela Guevara, Fellow in Medicine WCM Englander Institute for Precision Medicine, with patients referred by Cora Sternberg and @MCristofanill! Feb. 22 at 1 PM via Zoom

Perfect timing for the study to be published NEJM. #ctDNA🩸blood test for screening for colorectal cancer ✔️83% sensitivity ✔️90% specificity March is #ColorectalCancerAwarenessMonth 🩸is more practical 🆚 colonoscopy or 💩 test. Unmet need. OncoAlert nejm.org/doi/full/10.10…

That’s a wrap! It’s been an inspiring time at Focus on TOP #FTOP24! Thanks to our amazing faculty and to everyone who joined us, see you next year! Fabio Puglisi @MCristofanill Umberto Malapelle Maria Vittoria Dieci Luca Malorni Gustavo Baldassarre Rossana Roncato Marzia Del Re, PharmD, PhD #Oncology #liquidbiopsy

A novel #ClincialTrial open to enrollment Weill Cornell Medicine NewYork-Presbyterian is evaluating a PARP inhibitor for #BreastCancer patients with somatic BRCA1/2 mutations. Dr. Massimo Cristofanilli (@MCristofanill) explains this #research: bit.ly/3yEU7lQ #ASCO24

Dr. Massimo Cristofanilli (@MCristofanill) was involved with a large retrospective #research study shared at #ASCO24 looking at differences in the use of targeted therapies amongst different ethnicities: bit.ly/4dTBhYx

Cristofanilli CTC Laboratory delegation at #ASCO24! I am so glad to be part of this amazing group and have the opportunity to be mentored by @MCristofanill in #precision medicine and #LiquidBiopsy in #BreastCancer. Moving forward!🔜